Modeling Alzheimer's disease: From past to future

Frontiers in Pharmacology

Volumn 4 JUN, Issue , 2013, Pages

  Saraceno, Claudia ^a   Musardo, Stefano ^a   Marcello, Elena ^a   Pelucchi, Silvia ^a   Di Luca, Monica ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Alzheimer's disease; Amyloid; Animal models; Computational model; Secretases

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; AMYLOID BETA PROTEIN[3-42]; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; BETA SECRETASE; PRESENILIN; UNCLASSIFIED DRUG; GAMMA SECRETASE; NOOTROPIC AGENT;

ALZHEIMER DISEASE; AMNESIA; AMYLOID PLAQUE; APOE GENE; APP23TG MOUSE; BEHAVIOR DISORDER; BIOLOGICAL MODEL; CAENORHABDITIS ELEGANS; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; CRND8TG MOUSE; DISEASE ACTIVITY; DISEASE COURSE; DISEASE MODEL; DISEASE SEVERITY; GENETIC RISK; HUMAN; MATHEMATICAL COMPUTING; MATHEMATICAL MODEL; MOUSE STRAIN; NEUROMODULATION; NONHUMAN; ORTHOLOGY; PATHOGENESIS; PDAPP MOUSE; PLURIPOTENT STEM CELL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PSEN1 GENE; RAT STRAIN; REVIEW; RODENT; SENILE PLAQUE; SYNAPSE; SYNAPTIC RUNAWAY MODEL; TG19 MOUSE; TG2576 MOUSE; TGF344 AD RAT; TGJ20 MOUSE; TRANSGENIC MOUSE; ZEBRA FISH; AGING; COMPUTER MODEL; CYTOLOGY; DRUG EFFECT; GENE MUTATION; GENETICS; HEALTH CARE NEED; INVERTEBRATE; NEUROLOGY; PREVALENCE; PROTEIN CLEAVAGE; PROTEIN SYNTHESIS; TRANSGENIC ANIMAL;

EID: 84881645230     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2013.00077     Document Type: Review

References (221)

1. Albert, S. M., Del Castillo-Castaneda, C., Sano, M., Jacobs, D. M., Marder, K., Bell, K., et al. (1996). Quality of life in patients with Alzheimer's disease as reported by patient proxies. J. Am. Geriatr. Soc. 44, 1342-1347.
2. Allinson, T. M., Parkin, E. T., Turner, A. J., and Hooper, N. M. (2003). ADAMs family members as amyloid precursor protein alpha-secretases. J. Neurosci. Res. 74, 342-352. doi: 10.1002/jnr.10737
3. Andra, K., Abramowski, D., Duke, M., Probst, A., Wiederhold, K. H., Burki, K., et al. (1996). Expression of APP in transgenic mice: a comparison of neuron-specific promoters. Neurobiol. Aging 17, 183-190. doi: 10.1016/0197-4580(95)02066-7
4. Atkinson, R. C., and Shiffrin, R. M. (1968). "Human memory: a proposed system and its control processes," in The Psycology of Learning and Motivation, eds. K. W. Spence and J. T. Spence (New York: Academic Press), 89-195. doi: 10.1016/S1364-6613(00)01538-2
5. Bai, Q., and Burton, E. A. (2011). Zebrafish models of Tauopathy. Biochim. Biophys. Acta 1812, 353-363. doi: 10.1016/j.bbadis.2010.09.004
6. Bai, Q., Garver, J. A., Hukriede, N. A., and Burton, E. A. (2007). Generation of a transgenic zebrafish model of Tauopathy using a novel promoter element derived from the zebrafish eno2 gene. Nucleic Acids Res. 35, 6501-6516. doi: 10.1093/nar/gkm608
7. Balducci, C., Tonini, R., Zianni, E., Nazzaro, C., Fiordaliso, F., Salio, M., et al. (2010). Cognitive deficits associated with alteration of synaptic metaplasticity precede plaque deposition in AbetaPP23 transgenic mice. J. Alzheimers Dis. 21, 1367-1381. doi: 10.3233/JAD-2010-100675
8. Bao, H., Daniels, R. W., Macleod, G. T., Charlton, M. P., Atwood, H. L., and Zhang, B. (2005). AP180 maintains the distribution of synaptic and vesicle proteins in the nerve terminal and indirectly regulates the efficacy of Ca2+-triggered exocytosis. J. Neurophysiol. 94, 1888-1903. doi: 10.1152/jn.00080.2005
9. Barnes, C. A. (1979). Memory deficits associated with senescence: a neurophysiological and behavioral study in the rat. J. Comp. Physiol. Psychol. 93, 74-104. doi: 10.1037/h0077579
10. Barnes, C. A., Jung, M. W., Mcnaughton, B. L., Korol, D. L., Andreasson, K., and Worley, P. F. (1994). LTP saturation and spatial learning disruption: effects of task variables and saturation levels. J. Neurosci. 14, 5793-5806.
11. Bertram, L., Mcqueen, M. B., Mullin, K., Blacker, D., and Tanzi, R. E. (2007). Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat. Genet. 39, 17-23. doi: 10.1038/ng1934
12. Billings, L. M., Oddo, S., Green, K. N., Mcgaugh, J. L., and Laferla, F. M. (2005). Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron 45, 675-688. doi: 10.1016/j.neuron.2005.01.040
13. Boncristiano, S., Calhoun, M. E., Howard, V., Bondolfi, L., Kaeser, S. A., Wiederhold, K. H., et al. (2005). Neocortical synaptic bouton number is maintained despite robust amyloid deposition in APP23 transgenic mice. Neurobiol. Aging 26, 607-613. doi: 10.1016/j.neurobiolaging.2004.06.010
14. Borchelt, D. R., Thinakaran, G., Eckman, C. B., Lee, M. K., Davenport, F., Ratovitsky, T., et al. (1996). Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo. Neuron 17, 1005-1013. doi: 10.1016/S0896-6273(00)80230-5
15. Borchelt, D. R., Wong, P. C., Sisodia, S. S., and Price, D. L. (1998). Transgenic mouse models of Alzheimer's disease and amyotrophic lateral sclerosis. Brain Pathol. 8, 735-757. doi: 10.1111/j.1750-3639.1998.tb00198.x
16. Bornemann, K. D., and Staufenbiel, M. (2000). Transgenic mouse models of Alzheimer's disease. Ann. N. Y. Acad. Sci. 908, 260-266. doi: 10.1111/j.1749-6632.2000.tb06653.x
17. Brendza, R. P., Bales, K. R., Paul, S. M., and Holtzman, D. M. (2002). Role of apoE/Abeta interactions in Alzheimer's disease: insights from transgenic mouse models. Mol. Psychiatry 7, 132-135. doi: 10.1038/sj.mp.4001006
18. Brenner, S. (1974). The genetics of Caenorhabditis elegans. Genetics 77, 71-94. doi: 10.1002/ajmg.1320400103
19. Buxbaum, J. D., Christensen, J. L., Ruefli, A. A., Greengard, P., and Loring, J. F. (1993). Expression of APP in brains of transgenic mice containing the entire human APP gene. Biochem. Biophys. Res. Commun. 197, 639-645. doi: 10.1006/bbrc.1993.2527
20. Canas, P. M., Porciuncula, L. O., Cunha, G. M., Silva, C. G., Machado, N. J., Oliveira, J. M., et al. (2009). Adenosine A2A receptor blockade prevents synaptotoxicity and memory dysfunction caused by beta-amyloid peptides via p38 mitogen-activated protein kinase pathway. J. Neurosci. 29, 14741-14751. doi: 10.1523/JNEUROSCI.3728-09.2009
21. Carmine-Simmen, K., Proctor, T., Tschape, J., Poeck, B., Triphan, T., Strauss, R., et al. (2009). Neurotoxic effects induced by the Drosophila amyloid-beta peptide suggest a conserved toxic function. Neurobiol. Dis. 33, 274-281. doi: 10.1016/j.nbd.2008.10.014
22. Chamberlain, S. J., Chen, P. F., Ng, K. Y., Bourgois-Rocha, F., Lemtiri-Chlieh, F., Levine, E. S., et al. (2010). Induced pluripotent stem cell models of the genomic imprinting disorders Angelman and Prader-Willi syndromes. Proc. Natl. Acad. Sci. U.S.A. 107, 17668-17673. doi: 10.1073/pnas.1004487107
23. Chapman, P. F., White, G. L., Jones, M. W., Cooper-Blacketer, D., Marshall, V. J., Irizarry, M., et al. (1999). Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nat. Neurosci. 2, 271-276. doi: 10.1038/6374
24. Chen, G., Chen, K. S., Knox, J., Inglis, J., Bernard, A., Martin, S. J., et al. (2000). A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer's disease. Nature 408, 975-979. doi: 10.1038/35046031
25. Chin, J., Palop, J. J., Puolivali, J., Massaro, C., Bien-Ly, N., Gerstein, H., et al. (2005). Fyn kinase induces synaptic and cognitive impairments in a transgenic mouse model of Alzheimer's disease. J. Neurosci. 25, 9694-9703. doi: 10.1523/JNEUROSCI.2980-05.2005
26. Chishti, M. A., Yang, D. S., Janus, C., Phinney, A. L., Horne, P., Pearson, J., et al. (2001). Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J. Biol. Chem. 276, 21562-21570. doi: 10.1074/jbc.M100710200
27. Chomyn, A., Lai, S. T., Shakeley, R., Bresolin, N., Scarlato, G., and Attardi, G. (1994). Platelet-mediated transformation of mtDNA-less human cells: analysis of phenotypic variability among clones from normal individuals-and complementation behavior of the tRNALys mutation causing myoclonic epilepsy and ragged red fibers. Am. J. Hum. Genet. 54, 966-974.
28. Chui, D. H., Tanahashi, H., Ozawa, K., Ikeda, S., Checler, F., Ueda, O., et al. (1999). Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation. Nat. Med. 5, 560-564. doi: 10.1038/8438
29. Chung, H. M., and Struhl, G. (2001). Nicastrin is required for Presenilin-mediated transmembrane cleavage in Drosophila. Nat. Cell Biol. 3, 1129-1132. doi: 10.1038/ncb1201-1129
30. Cohen, R. M., Rezai-Zadeh, K., Weitz, T. M., Rentsendorj, A., Gate, D., Spivak, I., et al. (2013). A Transgenic Alzheimer Rat with Plaques, Tau Pathology, Behavioral Impairment, Oligomeric Abeta, and Frank Neuronal Loss. J. Neurosci. 33, 6245-6256. doi: 10.1523/JNEUROSCI.3672-12.2013
31. Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., et al. (1993). Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261, 921-923. doi: 10.1126/science.8346443
32. Crowther, D. C., Kinghorn, K. J., Miranda, E., Page, R., Curry, J. A., Duthie, F. A., et al. (2005). Intraneuronal Abeta, non-amyloid aggregates and neurodegeneration in a Drosophila model of Alzheimer's disease. Neuroscience 132, 123-135. doi: 10.1016/j.neuroscience.2004.12.025
33. Crowther, D. C., Page, R., Chandraratna, D., and Lomas, D. A. (2006). A Drosophila model of Alzheimer's disease. Methods Enzymol. 412, 234-255. doi: 10.1016/S0076-6879(06)12015-7
34. Daigle, I., and Li, C. (1993). apl-1, a Caenorhabditis elegans gene encoding a protein related to the human beta-amyloid protein precursor. Proc. Natl. Acad. Sci. U.S.A. 90, 12045-12049. doi: 10.1073/pnas.90.24.12045
35. Dickman, D. K., Lu, Z., Meinertzhagen, I. A., and Schwarz, T. L. (2006). Altered synaptic development and active zone spacing in endocytosis mutants. Curr. Biol. 16, 591-598. doi: 10.1016/j.cub.2006.02.058
36. Dimos, J. T., Rodolfa, K. T., Niakan, K. K., Weisenthal, L. M., Mitsumoto, H., Chung, W., et al. (2008). Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 321, 1218-1221. doi: 10.1126/science.1158799
37. Dinamarca, M. C., Colombres, M., Cerpa, W., Bonansco, C., and Inestrosa, N. C. (2008). Beta-amyloid oligomers affect the structure and function of the postsynaptic region: role of the Wnt signaling pathway. Neurodegener. Dis. 5, 149-152. doi: 10.1159/000113687
38. Dodart, J. C., Meziane, H., Mathis, C., Bales, K. R., Paul, S. M., and Ungerer, A. (1999). Behavioral disturbances in transgenic mice overexpressing the V717F beta-amyloid precursor protein. Behav. Neurosci. 113, 982-990. doi: 10.1037/0735-7044.113.5.982
39. Duch, W. (1997). "Platonic model of mind as an approximation to neurodynamics," in Brain-Like Computing and Intelligent Information System, eds S. I. Amari and N. Kasabov (Singapore: Springer), 491-512.
40. Duch, W. (2000). [Consciousness and models of brain dynamics]. Neurol. Neurochir. Pol. 34, 69-84. doi: 10.1371/journal.pbio.0050260
41. Duch, W. (2007). Computational models of dementia and neurological problems. Methods Mol. Biol. 401, 305-336. doi: 10.1007/978-1-59745-520-6_17
42. Duelli, R., Schrock, H., Kuschinsky, W., and Hoyer, S. (1994). Intracerebroventricular injection of streptozotocin induces discrete local changes in cerebral glucose utilization in rats. Int. J. Dev. Neurosci. 12, 737-743. doi: 10.1016/0736-5748(94)90053-1
43. Duff, K., Eckman, C., Zehr, C., Yu, X., Prada, C. M., Perez-Tur, J., et al. (1996). Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1. Nature 383, 710-713. doi: 10.1038/383710a0
44. Duff, K., and Suleman, F. (2004). Transgenic mouse models of Alzheimer's disease: how useful have they been for therapeutic development? Brief. Funct. Genomic. Proteomic. 3, 47-59. doi: 10.1093/bfgp/3.1.47
45. Durliat, M., Andre, M., and Babin, P. J. (2000). Conserved protein motifs and structural organization of a fish gene homologous to mammalian apolipoprotein E. Eur. J. Biochem. 267, 549-559. doi: 10.1046/j.1432-1327.2000.01033.x
46. Ebert, A. D., Yu, J., Rose, F. F. Jr., Mattis, V. B., Lorson, C. L., Thomson, J. A., et al. (2009). Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 457, 277-280. doi: 10.1038/nature07677
47. Edbauer, D., Winkler, E., Regula, J. T., Pesold, B., Steiner, H., and Haass, C. (2003). Reconstitution of gamma-secretase activity. Nat. Cell Biol. 5, 486-488. doi: 10.1038/ncb960
48. Eisen, J. S., and Smith, J. C. (2008). Controlling morpholino experiments: don't stop making antisense. Development 135, 1735-1743. doi: 10.1242/dev.001115
49. Ellis, H. M., and Horvitz, H. R. (1986). Genetic control of programmed cell death in the nematode C. elegans. Cell 44, 817-829. doi: 10.1016/0092-8674(86)90004-8
50. Epis, R., Marcello, E., Gardoni, F., Vastagh, C., Malinverno, M., Balducci, C., et al. (2010). Blocking ADAM10 synaptic trafficking generates a model of sporadic Alzheimer's disease. Brain 133, 3323-3335. doi: 10.1093/brain/awq217
51. Esch, F. S., Keim, P. S., Beattie, E. C., Blacher, R. W., Culwell, A. R., Oltersdorf, T., et al. (1990). Cleavage of amyloid beta peptide during constitutive processing of its precursor. Science 248, 1122-1124. doi: 10.1126/science.2111583
52. Esler, W. P., and Wolfe, M. S. (2001). A portrait of Alzheimer secretases-new features and familiar faces. Science 293, 1449-1454. doi: 10.1126/science.1064638
53. Ewald, C. Y., and Li, C. (2010). Understanding the molecular basis of Alzheimer's disease using a Caenorhabditis elegans model system. Brain Struct. Funct. 214, 263-283. doi: 10.1007/s00429-009-0235-3
54. Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A., Driver, S. E., and Mello, C. C. (1998). Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391, 806-811. doi: 10.1038/35888
55. Francis, R., Mcgrath, G., Zhang, J., Ruddy, D. A., Sym, M., Apfeld, J., et al. (2002). aph-1 and pen-2 are required for Notch pathway signaling, gamma-secretase cleavage of betaAPP, and presenilin protein accumulation. Dev. Cell 3, 85-97. doi: 10.1016/S1534-5807(02)00189-2
56. Frautschy, S. A., Yang, F., Irrizarry, M., Hyman, B., Saido, T. C., Hsiao, K., et al. (1998). Microglial response to amyloid plaques in APPsw transgenic mice. Am. J. Pathol. 152, 307-317.
57. Funato, H., Enya, M., Yoshimura, M., Morishima-Kawashima, M., and Ihara, Y. (1999). Presence of sodium dodecyl sulfate-stable amyloid beta-protein dimers in the hippocampus CA1 not exhibiting neurofibrillary tangle formation. Am. J. Pathol. 155, 23-28. doi: 10.1016/S0002-9440(10)65094-8
58. Gama Sosa, M. A., De Gasperi, R., and Elder, G. A. (2012). Modeling human neurodegenerative diseases in transgenic systems. Hum. Genet. 131, 535-563. doi: 10.1007/s00439-011-1119-1
59. Games, D., Adams, D., Alessandrini, R., Barbour, R., Berthelette, P., Blackwell, C., et al. (1995). Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature 373, 523-527. doi: 10.1038/373523a0
60. Garcia-Alloza, M., Robbins, E. M., Zhang-Nunes, S. X., Purcell, S. M., Betensky, R. A., Raju, S., et al. (2006). Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease. Neurobiol. Dis. 24, 516-524. doi: 10.1016/j.nbd.2006.08.017
61. Glenner, G. G., and Wong, C. W. (1984). Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120, 885-890. doi: 10.1016/S0006-291X(84)80190-4
62. Goate, A., Chartier-Harlin, M. C., Mullan, M., Brown, J., Crawford, F., Fidani, L., et al. (1991). Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349, 704-706. doi: 10.1038/349704a0
63. Goedert, M., and Spillantini, M. G. (2000). Tau mutations in frontotemporal dementia FTDP-17 and their relevance for Alzheimer's disease. Biochim. Biophys. Acta 1502, 110-121. doi: 10.1016/S0925-4439(00)00037-5
64. Gordon, M. N., King, D. L., Diamond, D. M., Jantzen, P. T., Boyett, K. V., Hope, C. E., et al. (2001). Correlation between cognitive deficits and Abeta deposits in transgenic APP+PS1 mice. Neurobiol. Aging 22, 377-385. doi: 10.1016/S0197-4580(00)00249-9
65. Gotz, J., Schild, A., Hoerndli, F., and Pennanen, L. (2004). Amyloid-induced neurofibrillary tangle formation in Alzheimer's disease: insight from transgenic mouse and tissue-culture models. Int. J. Dev. Neurosci. 22, 453-465. doi: 10.1016/j.ijdevneu.2004.07.013
66. Goutte, C., Hepler, W., Mickey, K. M., and Priess, J. R. (2000). aph-2 encodes a novel extracellular protein required for GLP-1-mediated signaling. Development 127, 2481-2492. doi: 10.1038/35024009
67. Greco, S. J., Bryan, K. J., Sarkar, S., Zhu, X., Smith, M. A., Ashford, J. W., et al. (2010). Leptin reduces pathology and improves memory in a transgenic mouse model of Alzheimer's disease. J. Alzheimers Dis. 19, 1155-1167. doi: 10.3233/JAD-2010-1308.
68. Greeve, I., Kretzschmar, D., Tschape, J. A., Beyn, A., Brellinger, C., Schweizer, M., et al. (2004). Age-dependent neurodegeneration and Alzheimer-amyloid plaque formation in transgenic Drosophila. J. Neurosci. 24, 3899-3906. doi: 10.1523/JNEUROSCI.0283-04.2004
69. Grskovic, M., Javaherian, A., Strulovici, B., and Daley, G. Q. (2011). Induced pluripotent stem cells-opportunities for disease modelling and drug discovery. Nat. Rev. Drug Discov. 10, 915-929. doi: 10.1038/nrd3577
70. Grueninger, F., Bohrmann, B., Czech, C., Ballard, T. M., Frey, J. R., Weidensteiner, C., et al. (2010). Phosphorylation of Tau at S422 is enhanced by Abeta in TauPS2APP triple transgenic mice. Neurobiol. Dis. 37, 294-306. doi: 10.1016/j.nbd.2009.09.004
71. Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M., and Binder, L. I. (1986). Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc. Natl. Acad. Sci. U.S.A. 83, 4913-4917. doi: 10.1073/pnas.83.13.4913
72. Grunwald, D. J., and Eisen, J. S. (2002). Headwaters of the zebrafish - emergence of a new model vertebrate. Nat. Rev. Genet. 3, 717-724. doi: 10.1038/nrg892
73. Guo, S. (2004). Linking genes to brain, behavior and neurological diseases: what can we learn from zebrafish? Genes Brain Behav. 3, 63-74. doi: 10.1046/j.1601-183X.2003.00053.x
74. Haass, C. (2004). Take five-BACE and the gamma-secretase quartet conduct Alzheimer's amyloid beta-peptide generation. EMBO J. 23, 483-488. doi: 10.1038/sj.emboj.7600061
75. Hardy, J., and Selkoe, D. J. (2002). The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356. doi: 10.1126/science.1072994
76. Hartmann, D., De Strooper, B., Serneels, L., Craessaerts, K., Herreman, A., Annaert, W., et al. (2002). The disintegrin/metalloprotease ADAM 10 is essential for Notch signalling but not for alpha-secretase activity in fibroblasts. Hum. Mol. Genet. 11, 2615-2624. doi: 10.1093/hmg/11.21.2615
77. Hasselmo, M. E. (1991). Runaway synaptic modification in model of cortex: implication for Alzheimer's disease. Neural Netw. 7, 13-40. doi: 10.1016/0893-6080(94)90053-1
78. Hasselmo, M. E. (1997). A computational model of the progression of Alzheimer's disease. MD Comput. 14, 181-191. doi: 10.1016/j.neuroimage.2012.07.059
79. Hasselmo, M. E., and McClelland, J. L. (1999). Neural models of memory. Curr. Opin. Neurobiol. 9, 184-188. doi: 10.1016/S0959-4388(99)80025-7
80. Herreman, A., Hartmann, D., Annaert, W., Saftig, P., Craessaerts, K., Serneels, L., et al. (1999). Presenilin 2 deficiency causes a mild pulmonary phenotype and no changes in amyloid precursor protein processing but enhances the embryonic lethal phenotype of presenilin 1 deficiency. Proc. Natl. Acad. Sci. U.S.A. 96, 11872-11877. doi: 10.1073/pnas.96.21.11872
81. Holcomb, L., Gordon, M. N., McGowan, E., Yu, X., Benkovic, S., Jantzen, P., et al. (1998). Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat. Med. 4, 97-100. doi: 10.1038/nm0198-097
82. Hong, C. S., and Koo, E. H. (1997). Isolation and characterization of Drosophila presenilin homolog. Neuroreport 8, 665-668. doi: 10.1097/00001756-199702100-00017
83. Horn, D., Levy, L., and Ruppin, E. (1996). Neuronal-based synapic compensation: a computational study in Alzheimr's disease. Neural Comput. 8, 1227-1243. doi: 10.1162/neco.1996.8.6.1227
84. Horn, D., Ruppin, E., Usher, M., and Herrmann, M. (1993). Neural network modeling of memory deterioration in Alzheimer's disease. Neural Comput. 5, 736-749. doi: 10.1162/neco.1993.5.5.736
85. Hornsten, A., Lieberthal, J., Fadia, S., Malins, R., Ha, L., Xu, X., et al. (2007). APL-1, a Caenorhabditis elegans protein related to the human beta-amyloid precursor protein, is essential for viability. Proc. Natl. Acad. Sci. U.S.A. 104, 1971-1976. doi: 10.1073/pnas.0603997104
86. Howlett, D. R., Bowler, K., Soden, P. E., Riddell, D., Davis, J. B., Richardson, J. C., et al. (2008). Abeta deposition and related pathology in an APP x PS1 transgenic mouse model of Alzheimer's disease. Histol. Histopathol. 23, 67-76. doi: 10.1371/journal.pone.0007931
87. Howlett, D. R., Richardson, J. C., Austin, A., Parsons, A. A., Bate, S. T., Davies, D. C., et al. (2004). Cognitive correlates of Abeta deposition in male and female mice bearing amyloid precursor protein and presenilin-1 mutant transgenes. Brain Res. 1017, 130-136. doi: 10.1016/j.brainres.2004.05.029
88. Hoyer, S. (1992). Oxidative energy metabolism in Alzheimer brain. Studies in early-onset and late-onset cases. Mol. Chem. Neuropathol. 16, 207-224. doi: 10.1007/BF03159971
89. Hoyer, S., and Lannert, H. (1999). Inhibition of the neuronal insulin receptor causes Alzheimer-like disturbances in oxidative/energy brain metabolism and in behavior in adult rats. Ann. N. Y. Acad. Sci. 893, 301-303. doi: 10.1111/j.1749-6632.1999.tb07842.x
90. Hoyer, S., Lee, S. K., Loffler, T., and Schliebs, R. (2000). Inhibition of the neuronal insulin receptor. An in vivo model for sporadic Alzheimer disease? Ann. N. Y. Acad. Sci. 920, 256-258. doi: 10.1111/j.1749-6632.2000.tb06932.x
91. Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., et al. (1996). Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274, 99-102. doi: 10.1126/science.274.5284.99
92. Hu, X., Hicks, C. W., He, W., Wong, P., Macklin, W. B., Trapp, B. D., et al. (2006). Bace1 modulates myelination in the central and peripheral nervous system. Nat. Neurosci. 9, 1520-1525. doi: 10.1038/nn1797
93. Huang, W. H., Sheng, R., and Hu, Y. Z. (2009). Progress in the development of nonpeptidomimetic BACE 1 inhibitors for Alzheimer's disease. Curr. Med. Chem. 16, 1806-1820. doi: 10.2174/092986709788186174
94. Iijima, K., Chiang, H. C., Hearn, S. A., Hakker, I., Gatt, A., Shenton, C., et al. (2008). Abeta42 mutants with different aggregation profiles induce distinct pathologies in Drosophila. PLoS ONE 3:e1703. doi: 10.1371/journal.pone.0001703
95. Iijima, K., Liu, H. P., Chiang, A. S., Hearn, S. A., Konsolaki, M., and Zhong, Y. (2004). Dissecting the pathological effects of human Abeta40 and Abeta42 in Drosophila: a potential model for Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 101, 6623-6628. doi: 10.1073/pnas.0400895101
96. Irizarry, M. C., Mcnamara, M., Fedorchak, K., Hsiao, K., and Hyman, B. T. (1997a). APPSw transgenic mice develop age-related A beta deposits and neuropil abnormalities, but no neuronal loss in CA1. J. Neuropathol. Exp. Neurol. 56, 965-973. doi: 10.1097/00005072-199709000-00002
97. Irizarry, M. C., Soriano, F., Mcnamara, M., Page, K. J., Schenk, D., Games, D., et al. (1997b). Abeta deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse. J. Neurosci. 17, 7053-7059.
98. Israel, M. A., Yuan, S. H., Bardy, C., Reyna, S. M., Mu, Y., Herrera, C., et al. (2012). Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells. Nature 482, 216-220. doi: 10.1038/nature10821
99. Jacobsen, J. S., Wu, C. C., Redwine, J. M., Comery, T. A., Arias, R., Bowlby, M., et al. (2006). Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 103, 5161-5166. doi: 10.1073/pnas.0600948103
100. Janus, C., Pearson, J., Mclaurin, J., Mathews, P. M., Jiang, Y., Schmidt, S. D., et al. (2000). A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature 408, 979-982. doi: 10.1038/35050110
101. Janus, C., and Westaway, D. (2001). Transgenic mouse models of Alzheimer's disease. Physiol. Behav. 73, 873-886. doi: 10.1016/S0031-9384(01)00524-8
102. Jarriault, S., and Greenwald, I. (2005). Evidence for functional redundancy between C. elegans ADAM proteins SUP-17/Kuzbanian and ADM-4/TACE. Dev. Biol. 287, 1-10. doi: 10.1016/j.ydbio.2005.08.014
103. Johnson-Wood, K., Lee, M., Motter, R., Hu, K., Gordon, G., Barbour, R., et al. (1997). Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 94, 1550-1555. doi: 10.1073/pnas.94.4.1550
104. Jorissen, E., Prox, J., Bernreuther, C., Weber, S., Schwanbeck, R., Serneels, L., et al. (2010). The disintegrin/metalloproteinase ADAM10 is essential for the establishment of the brain cortex. J. Neurosci. 30, 4833-4844. doi: 10.1523/JNEUROSCI.5221-09.2010
105. Joshi, P., Liang, J. O., Dimonte, K., Sullivan, J., and Pimplikar, S. W. (2009). Amyloid precursor protein is required for convergent-extension movements during Zebrafish development. Dev. Biol. 335, 1-11. doi: 10.1016/j.ydbio.2009.07.041
106. Kelly, P. H., Bondolfi, L., Hunziker, D., Schlecht, H. P., Carver, K., Maguire, E., et al. (2003). Progressive age-related impairment of cognitive behavior in APP23 transgenic mice. Neurobiol. Aging 24, 365-378. doi: 10.1016/S0197-4580(02)00098-2
107. Kim, M., Suh, J., Romano, D., Truong, M. H., Mullin, K., Hooli, B., et al. (2009). Potential late-onset alzheimer's disease-associated mutations in the ADAM10 gene attenuate {alpha}-secretase activity. Hum. Mol. Genet. 18, 3987-3996. doi: 10.1093/hmg/ddp323
108. Kimberly, W. T., Lavoie, M. J., Ostaszewski, B. L., Ye, W., Wolfe, M. S., and Selkoe, D. J. (2003). Gamma-secretase is a membrane protein complex comprised of presenilin, nicastrin, Aph-1, and Pen-2. Proc. Natl. Acad. Sci. U.S.A. 100, 6382-6387. doi: 10.1073/pnas.1037392100
109. Kimmel, C. B., Ballard, W. W., Kimmel, S. R., Ullmann, B., and Schilling, T. F. (1995). Stages of embryonic development of the zebrafish. Dev. Dyn. 203, 253-310. doi: 10.1002/aja.1002030302
110. Klein, W. L., Krafft, G. A., and Finch, C. E. (2001). Targeting small Abeta oligomers: the solution to an Alzheimer's disease conundrum? Trends Neurosci. 24, 219-224. doi: 10.1016/S0166-2236(00)01749-5
111. Ku, S., Soragni, E., Campau, E., Thomas, E. A., Altun, G., Laurent, L. C., et al. (2010). Friedreich's ataxia induced pluripotent stem cells model intergenerational GAATTC triplet repeat instability. Cell Stem Cell 7, 631-637. doi: 10.1016/j.stem.2010.09.014
112. Kuhn, P. H., Wang, H., Dislich, B., Colombo, A., Zeitschel, U., Ellwart, J. W., et al. (2010). ADAM10 is the physiologically relevant, constitutive alpha-secretase of the amyloid precursor protein in primary neurons. EMBO J. 29, 3020-3032. doi: 10.1038/emboj.2010.167
113. Kurt, M. A., Davies, D. C., Kidd, M., Duff, K., Rolph, S. C., Jennings, K. H., et al. (2001). Neurodegenerative changes associated with beta-amyloid deposition in the brains of mice carrying mutant amyloid precursor protein and mutant presenilin-1 transgenes. Exp. Neurol. 171, 59-71. doi: 10.1006/exnr.2001.7717
114. LaFerla, F. M., and Green, K. N. (2012). Animal models of Alzheimer disease. Cold Spring Harb. Perspect. Med. 2, pii: a006320. doi: 10.1101/cshperspect.a006320
115. Lamb, B. T., Sisodia, S. S., Lawler, A. M., Slunt, H. H., Kitt, C. A., Kearns, W. G., et al. (1993). Introduction and expression of the 400 kilobase amyloid precursor protein gene in transgenic mice [corrected]. Nat. Genet. 5, 22-30. doi: 10.1038/ng0993-22
116. Lannert, H., and Hoyer, S. (1998). Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats. Behav. Neurosci. 112, 1199-1208. doi: 10.1037/0735-7044.112.5.1199
117. Larson, J., Lynch, G., Games, D., and Seubert, P. (1999). Alterations in synaptic transmission and long-term potentiation in hippocampal slices from young and aged PDAPP mice. Brain Res. 840, 23-35. doi: 10.1016/S0006-8993(99)01698-4
118. Lee, D. C., Sunnarborg, S. W., Hinkle, C. L., Myers, T. J., Stevenson, M. Y., Russell, W. E., et al. (2003). TACE/ADAM17 processing of EGFR ligands indicates a role as a physiological convertase. Ann. N. Y. Acad. Sci. 995, 22-38. doi: 10.1111/j.1749-6632.2003.tb03207.x
119. Lee, G., Papapetrou, E. P., Kim, H., Chambers, S. M., Tomishima, M. J., Fasano, C. A., et al. (2009). Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature 461, 402-406. doi: 10.1038/nature08320
120. Lee, H. E., Kim, D. H., Park, S. J., Kim, J. M., Lee, Y. W., Jung, J. M., et al. (2012). Neuroprotective effect of sinapic acid in a mouse model of amyloid beta(1-42) protein-induced Alzheimer's disease. Pharmacol. Biochem. Behav. 103, 260-266. doi: 10.1016/j.pbb.2012.08.015
121. Lee, J. A., and Cole, G. J. (2007). Generation of transgenic zebrafish expressing green fluorescent protein under control of zebrafish amyloid precursor protein gene regulatory elements. Zebrafish 4, 277-286. doi: 10.1089/zeb.2007.0516
122. Lee, M. K., Borchelt, D. R., Kim, G., Thinakaran, G., Slunt, H. H., Ratovitski, T., et al. (1997). Hyperaccumulation of FAD-linked presenilin 1 variants in vivo. Nat. Med. 3, 756-760. doi: 10.1038/nm0797-756
123. Lester-Coll, N., Rivera, E. J., Soscia, S. J., Doiron, K., Wands, J. R.,De La Monte, S. M. (2006). Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer's disease. J. Alzheimers Dis. 9, 13-33.
124. Levitan, D., and Greenwald, I. (1995). Facilitation of lin-12-mediated signalling by sel-12, a Caenorhabditis elegans S182 Alzheimer's disease gene. Nature 377, 351-354. doi: 10.1038/377351a0
125. Levitan, D., and Greenwald, I. (1998). Effects of SEL-12 presenilin on LIN-12 localization and function in Caenorhabditis elegans. Development 125, 3599-3606.
126. Li, X., and Greenwald, I. (1997). HOP-1, a Caenorhabditis elegans presenilin, appears to be functionally redundant with SEL-12 presenilin and to facilitate LIN-12 and GLP-1 signaling. Proc. Natl. Acad. Sci. U.S.A. 94, 12204-12209. doi: 10.1073/pnas.94.22.12204
127. Lieschke, G. J., and Currie, P. D. (2007). Animal models of human disease: zebrafish swim into view. Nat. Rev. Genet. 8, 353-367. doi: 10.1038/nrg2091
128. Lin, Y. J., Seroude, L., and Benzer, S. (1998). Extended life-span and stress resistance in the Drosophila mutant methuselah. Science 282, 943-946. doi: 10.1126/science.282.5390.943
129. Ljubuncic, P., and Reznick, A. Z. (2009). The evolutionary theories of aging revisited-a mini-review. Gerontology 55, 205-216. doi: 10.1159/000200772
130. Luo, L., Tully, T., and White, K. (1992). Human amyloid precursor protein ameliorates behavioral deficit of flies deleted for Appl gene. Neuron 9, 595-605. doi: 10.1016/0896-6273(92)90024-8
131. Luo, L. Q., Martin-Morris, L. E., and White, K. (1990). Identification, secretion, and neural expression of APPL, a Drosophila protein similar to human amyloid protein precursor. J. Neurosci. 10, 3849-3861.
132. Luo, Y., Bolon, B., Kahn, S., Bennett, B. D., Babu-Khan, S., Denis, P., et al. (2001). Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation. Nat. Neurosci. 4, 231-232. doi: 10.1038/85059
133. Marcello, E., Gardoni, F., Mauceri, D., Romorini, S., Jeromin, A., Epis, R., et al. (2007). Synapse-associated protein-97 mediates alpha-secretase ADAM10 trafficking and promotes its activity. J. Neurosci. 27, 1682-1691. doi: 10.1523/JNEUROSCI.3439-06.2007
134. Marchetto, M. C., Carromeu, C., Acab, A., Yu, D., Yeo, G. W., Mu, Y., et al. (2010). A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell 143, 527-539. doi: 10.1016/j.cell.2010.10.016
135. Martin-Morris, L. E., and White, K. (1990). The Drosophila transcript encoded by the beta-amyloid protein precursor-like gene is restricted to the nervous system. Development 110, 185-195.
136. Mathew, D., Popescu, A., and Budnik, V. (2003). Drosophila amphiphysin functions during synaptic Fasciclin II membrane cycling. J. Neurosci. 23, 10710-10716.
137. McClelland, J. L., Mcnaughton, B. L., and O'reilly, R. C. (1995). Why there are complementary learning systems in the hippocampus and neocortex: insights from the successes and failures of connectionist models of learning and memory. Psychol. Rev. 102, 419-457. doi: 10.1037/0033-295X.102.3.419
138. McClelland, J. L., and Rumelhart, D. E. (1986). Parallel Distributed Processing: exploration in the Microstructure of Cognition. Cambridge: MIT Press.
139. McColl, G., Roberts, B. R., Gunn, A. P., Perez, K. A., Tew, D. J., Masters, C. L., et al. (2009). The Caenorhabditis elegans A beta 1-42 model of Alzheimer disease predominantly expresses A beta 3-42. J. Biol. Chem. 284, 22697-22702. doi: 10.1074/jbc.C109.028514
140. McColl, G., Roberts, B. R., Pukala, T. L., Kenche, V. B., Roberts, C. M., Link, C. D., et al. (2012). Utility of an improved model of amyloid-beta (Abeta(1)(-)(4)(2)) toxicity in Caenorhabditis elegans for drug screening for Alzheimer's disease. Mol. Neurodegener. 7, 57. doi: 10.1186/1750-1326-7-57
141. McCool, M. F., Varty, G. B., Del Vecchio, R. A., Kazdoba, T. M., Parker, E. M., Hunter, J. C., et al. (2003). Increased auditory startle response and reduced prepulse inhibition of startle in transgenic mice expressing a double mutant form of amyloid precursor protein. Brain Res. 994, 99-106. doi: 10.1016/j.brainres.2003.09.025
142. McGowan, E., Sanders, S., Iwatsubo, T., Takeuchi, A., Saido, T., Zehr, C., et al. (1999). Amyloid phenotype characterization of transgenic mice overexpressing both mutant amyloid precursor protein and mutant presenilin 1 transgenes. Neurobiol. Dis. 6, 231-244. doi: 10.1006/nbdi.1999.0243
143. McLean, C. A., Cherny, R. A., Fraser, F. W., Fuller, S. J., Smith, M. J., Beyreuther, K., et al. (1999). Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann. Neurol. 46, 860-866. doi: 10.1002/1531-8249(199912)46:6
144. Moechars, D., Dewachter, I., Lorent, K., Reverse, D., Baekelandt, V., Naidu, A., et al. (1999). Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain. J. Biol. Chem. 274, 6483-6492. doi: 10.1074/jbc.274.10.6483
145. Moran, P. M., Higgins, L. S., Cordell, B., and Moser, P. C. (1995). Age-related learning deficits in transgenic mice expressing the 751-amino acid isoform of human beta-amyloid precursor protein. Proc. Natl. Acad. Sci. U.S.A. 92, 5341-5345. doi: 10.1073/pnas.92.12.5341
146. Mucke, L., Masliah, E., Yu, G. Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., et al. (2000). High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J. Neurosci. 20, 4050-4058.
147. Mullan, M., Crawford, F., Axelman, K., Houlden, H., Lilius, L., Winblad, B., et al. (1992). A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid. Nat. Genet. 1, 345-347. doi: 10.1038/ng0892-345
148. Murrell, J., Farlow, M., Ghetti, B., and Benson, M. D. (1991). A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science 254, 97-99. doi: 10.1126/science.1925564
149. Musa, A., Lehrach, H., and Russo, V. A. (2001). Distinct expression patterns of two zebrafish homologues of the human APP gene during embryonic development. Dev. Genes Evol. 211, 563-567. doi: 10.1007/s00427-001-0189-9
150. Nasevicius, A., and Ekker, S. C. (2000). Effective targeted gene 'knockdown' in zebrafish. Nat. Genet. 26, 216-220. doi: 10.1038/79951
151. Nguyen, H. N., Byers, B., Cord, B., Shcheglovitov, A., Byrne, J., Gujar, P., et al. (2011). LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress. Cell Stem Cell 8, 267-280. doi: 10.1016/j.stem.2011.01.013
152. Nilsberth, C., Westlind-Danielsson, A., Eckman, C. B., Condron, M. M., Axelman, K., Forsell, C., et al. (2001). The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation. Nat. Neurosci. 4, 887-893. doi: 10.1038/nn0901-887
153. Nonet, M. L., Holgado, A. M., Brewer, F., Serpe, C. J., Norbeck, B. A., Holleran, J., et al. (1999). UNC-11, a Caenorhabditis elegans AP180 homologue, regulates the size and protein composition of synaptic vesicles. Mol. Biol. Cell 10, 2343-2360.
154. Nusslein-Volhard, C., and Wieschaus, E. (1980). Mutations affecting segment number and polarity in Drosophila. Nature 287, 795-801. doi: 10.1038/287795a0
155. Oddo, S., Billings, L., Kesslak, J. P., Cribbs, D. H., and Laferla, F. M. (2004). Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome. Neuron 43, 321-332. doi: 10.1016/j.neuron.2004.07.003
156. Oddo, S., Caccamo, A., Kitazawa, M., Tseng, B. P., and Laferla, F. M. (2003a). Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease. Neurobiol. Aging 24, 1063-1070. doi: 10.1016/j.neurobiolaging.2003.08.012
157. Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., et al. (2003b). Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 39, 409-421. doi: 10.1016/S0896-6273(03)00434-3
158. Oddo, S., Caccamo, A., Smith, I. F., Green, K. N., and Laferla, F. M. (2006). A dynamic relationship between intracellular and extracellular pools of Abeta. Am. J. Pathol. 168, 184-194. doi: 10.2353/ajpath.2006.050593
159. Onyango, I., Khan, S., Miller, B., Swerdlow, R., Trimmer, P., and Bennett, P. Jr. (2006). Mitochondrial genomic contribution to mitochondrial dysfunction in Alzheimer's disease. J. Alzheimers. Dis. 9, 183-193.
160. Paganetti, P. A., Lis, M., Klafki, H. W., and Staufenbiel, M. (1996). Amyloid precursor protein truncated at any of the gamma-secretase sites is not cleaved to beta-amyloid. J. Neurosci. Res. 46, 283-293. doi: 10.1002/(SICI)1097-4547(19961101)46:3
161. Panula, P., Sallinen, V., Sundvik, M., Kolehmainen, J., Torkko, V., Tiittula, A., et al. (2006). Modulatory neurotransmitter systems and behavior: towards zebrafish models of neurodegenerative diseases. Zebrafish 3, 235-247. doi: 10.1089/zeb.2006.3.235
162. Park, I. H., Arora, N., Huo, H., Maherali, N., Ahfeldt, T., Shimamura, A., et al. (2008). Disease-specific induced pluripotent stem cells. Cell 134, 877-886. doi: 10.1016/j.cell.2008.07.041
163. Perez, M., Ribe, E., Rubio, A., Lim, F., Moran, M. A., Ramos, P. G., et al. (2005). Characterization of a double (amyloid precursor protein-tau) transgenic: tau phosphorylation and aggregation. Neuroscience 130, 339-347. doi: 10.1016/j.neuroscience.2004.09.029
164. Pietropaolo, S., Feldon, J., and Yee, B. K. (2008). Age-dependent phenotypic characteristics of a triple transgenic mouse model of Alzheimer disease. Behav. Neurosci. 122, 733-747. doi: 10.1037/a0012520
165. Plaschke, K., and Hoyer, S. (1993). Action of the diabetogenic drug streptozotocin on glycolytic and glycogenolytic metabolism in adult rat brain cortex and hippocampus. Int. J. Dev. Neurosci. 11, 477-483. doi: 10.1016/0736-5748(93)90021-5
166. Plaschke, K., Muller, D., and Hoyer, S. (2010). Insulin-resistant brain state (IRBS) changes membrane composition of fatty acids in temporal and entorhinal brain cortices of rats: relevance to sporadic Alzheimer's disease? J. Neural Transm. 117, 1419-1422. doi: 10.1007/s00702-010-0523-3
167. Postlethwait, J. H., Woods, I. G., Ngo-Hazelett, P., Yan, Y. L., Kelly, P. D., Chu, F., et al. (2000). Zebrafish comparative genomics and the origins of vertebrate chromosomes. Genome Res. 10, 1890-1902. doi: 10.1101/gr.164800
168. Quon, D., Wang, Y., Catalano, R., Scardina, J. M., Murakami, K., and Cordell, B. (1991). Formation of beta-amyloid protein deposits in brains of transgenic mice. Nature 352, 239-241. doi: 10.1038/352239a0
169. Reiter, L. T., Potocki, L., Chien, S., Gribskov, M., and Bier, E. (2001). A systematic analysis of human disease-associated gene sequences in Drosophila melanogaster. Genome Res. 11, 1114-1125. doi: 10.1101/gr.169101
170. Rhein, V., Song, X., Wiesner, A., Ittner, L. M., Baysang, G., Meier, F., et al. (2009). Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice. Proc. Natl. Acad. Sci. U.S.A. 106, 20057-20062. doi: 10.1073/pnas.0905529106
171. Ribe, E. M., Perez, M., Puig, B., Gich, I., Lim, F., Cuadrado, M., et al. (2005). Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic mice. Neurobiol. Dis. 20, 814-822. doi: 10.1016/j.nbd.2005.05.027
172. Rival, T., Page, R. M., Chandraratna, D. S., Sendall, T. J., Ryder, E., Liu, B., et al. (2009). Fenton chemistry and oxidative stress mediate the toxicity of the beta-amyloid peptide in a Drosophila model of Alzheimer's disease. Eur. J. Neurosci. 29, 1335-1347. doi: 10.1111/j.1460-9568.2009.06701.x
173. Roberds, S. L., Anderson, J., Basi, G., Bienkowski, M. J., Branstetter, D. G., Chen, K. S., et al. (2001). BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer's disease therapeutics. Hum. Mol. Genet. 10, 1317-1324. doi: 10.1093/hmg/10.12.1317
174. Roher, A. E., and Kokjohn, T. A. (2002). Of mice and men: the relevance of transgenic mice Abeta immunizations to Alzheimer's disease. J. Alzheimers Dis. 4, 431-434. doi: 10.1038/35050116
175. Rooke, J., Pan, D., Xu, T., and Rubin, G. M. (1996). KUZ, a conserved metalloprotease-disintegrin protein with two roles in Drosophila neurogenesis. Science 273, 1227-1231. doi: 10.1126/science.273.5279.1227
176. Rosen, D. R., Martin-Morris, L., Luo, L. Q., and White, K. (1989). A Drosophila gene encoding a protein resembling the human beta-amyloid protein precursor. Proc. Natl. Acad. Sci. U.S.A. 86, 2478-2482. doi: 10.1073/pnas.86.7.2478
177. Ruppin, E., and Reggia, J. A. (1995). A neural model of memory impairment in diffuse cerebral atrophy. Br. J. Psychiatry 166, 19-28. doi: 10.1192/bjp.166.1.19
178. Sarasa, M., Sorribas, V., Terradoa, J., Climent, S., Palacios, J. M., and Mengod, G. (2000). Alzheimer beta-amyloid precursor proteins display specific patterns of expression during embryogenesis. Mech. Dev. 94, 233-236. doi: 10.1016/S0925-4773(00)00297-5
179. Saunders, A. M., Strittmatter, W. J., Schmechel, D., George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., et al. (1993). Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43, 1467-1472. doi: 10.1212/WNL.43.8.1467
180. Saura, C. A., Choi, S. Y., Beglopoulos, V., Malkani, S., Zhang, D., Shankaranarayana Rao, B. S., et al. (2004). Loss of presenilin function causes impairments of memory and synaptic plasticity followed by age-dependent neurodegeneration. Neuron 42, 23-36. doi: 10.1016/S0896-6273(04)00182-5
181. Savonenko, A., Xu, G. M., Melnikova, T., Morton, J. L., Gonzales, V., Wong, M. P., et al. (2005). Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities. Neurobiol. Dis. 18, 602-617. doi: 10.1016/j.nbd.2004.10.022
182. Selkoe, D. J. (2000). Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein. Ann. N. Y. Acad. Sci. 924, 17-25. doi: 10.1111/j.1749-6632.2000.tb05554.x
183. Selkoe, D. J. (2001). Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 81, 741-766.
184. Shankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., et al. (2008). Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat. Med. 14, 837-842. doi: 10.1038/nm1782
185. Shen, J., Bronson, R. T., Chen, D. F., Xia, W., Selkoe, D. J., and Tonegawa, S. (1997). Skeletal and CNS defects in Presenilin-1-deficient mice. Cell 89, 629-639. doi: 10.1016/S0092-8674(00)80244-5
186. Shen, J., and Kelleher, R. J. III (2007). The presenilin hypothesis of Alzheimer's disease: evidence for a loss-of-function pathogenic mechanism. Proc. Natl. Acad. Sci. U.S.A. 104, 403-409. doi: 10.1073/pnas.0608332104
187. Siegle, G. J., and Hasselmo, M. E. (2002). Using connectionist models to guide assessment of psychological disorder. Psychol. Assess. 14, 263-278. doi: 10.1037/1040-3590.14.3.263
188. Smith, E. D., Tsuchiya, M., Fox, L. A., Dang, N., Hu, D., Kerr, E. O., et al. (2008). Quantitative evidence for conserved longevity pathways between divergent eukaryotic species. Genome Res. 18, 564-570. doi: 10.1101/gr.074724.107
189. Soldner, F., Hockemeyer, D., Beard, C., Gao, Q., Bell, G. W., Cook, E. G., et al. (2009). Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 136, 964-977. doi: 10.1016/j.cell.2009.02.013
190. Stokin, G. B., Almenar-Queralt, A., Gunawardena, S., Rodrigues, E. M., Falzone, T., Kim, J., et al. (2008). Amyloid precursor protein-induced axonopathies are independent of amyloid-beta peptides. Hum. Mol. Genet. 17, 3474-3486. doi: 10.1093/hmg/ddn240
191. Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K. H., Mistl, C., Rothacher, S., et al. (1997). Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc. Natl. Acad. Sci. U.S.A. 94, 13287-13292. doi: 10.1073/pnas.94.24.13287
192. Swerdlow, R. H., and Hanna, G. R. (1996). Behcet's disease: presentation with sagittal sinus thrombosis diagnosed noninvasively. Headache 36, 115-118. doi: 10.1046/j.1526-4610.1996.3602115.x
193. Swerdlow, R. H., Parks, J. K., Miller, S. W., Tuttle, J. B., Trimmer, P. A., Sheehan, J. P., et al. (1996). Origin and functional consequences of the complex I defect in Parkinson's disease. Ann. Neurol. 40, 663-671. doi: 10.1002/ana.410400417
194. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., et al. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872. doi: 10.1016/j.cell.2007.11.019
195. Takahashi, R. H., Milner, T. A., Li, F., Nam, E. E., Edgar, M. A., Yamaguchi, H., et al. (2002). Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology. Am. J. Pathol. 161, 1869-1879. doi: 10.1016/S0002-9440(10)64463-X
196. Takei, Y., Teng, J., Harada, A., and Hirokawa, N. (2000). Defects in axonal elongation and neuronal migration in mice with disrupted tau and map1b genes. J. Cell Biol. 150, 989-1000. doi: 10.1083/jcb.150.5.989
197. Tax, F. E., Thomas, J. H., Ferguson, E. L., and Horvitz, H. R. (1997). Identification and characterization of genes that interact with lin-12 in Caenorhabditis elegans. Genetics 147, 1675-1695.
198. Teschendorf, D., and Link, C. D. (2009). What have worm models told us about the mechanisms of neuronal dysfunction in human neurodegenerative diseases? Mol. Neurodegener. 4, 38. doi: 10.1186/1750-1326-4-38
199. Tomobe, K., and Nomura, Y. (2009). Neurochemistry, neuropathology, and heredity in SAMP8: a mouse model of senescence. Neurochem. Res. 34, 660-669. doi: 10.1007/s11064-009-9923-x
200. Torres-Aleman, I. (2008). Mouse models of Alzheimer's dementia: current concepts and new trends. Endocrinology 149, 5952-5957. doi: 10.1210/en.2008-0905
201. Van Dam, D.,De Deyn, P. P. (2006). Drug discovery in dementia: the role of rodent models. Nat. Rev. Drug Discov. 5, 956-970. doi: 10.1038/nrd2075
202. Van Dam, D., D'hooge, R., Staufenbiel, M., Van Ginneken, C., Van Meir, F.,De Deyn, P. P. (2003). Age-dependent cognitive decline in the APP23 model precedes amyloid deposition. Eur. J. Neurosci. 17, 388-396. doi: 10.1046/j.1460-9568.2003.02444.x
203. Walsh, D. M., and Selkoe, D. J. (2007). A beta oligomers - a decade of discovery. J. Neurochem. 101, 1172-1184. doi: 10.1111/j.1471-4159.2006.04426.x
204. Wang, Q., Walsh, D. M., Rowan, M. J., Selkoe, D. J., and Anwyl, R. (2004). Block of long-term potentiation by naturally secreted and synthetic amyloid beta-peptide in hippocampal slices is mediated via activation of the kinases c-Jun N-terminal kinase, cyclin-dependent kinase 5, and p38 mitogen-activated protein kinase as well as metabotropic glutamate receptor type 5. J. Neurosci. 24, 3370-3378. doi: 10.1523/JNEUROSCI.1633-03.2004
205. Wen, C., Levitan, D., Li, X., and Greenwald, I. (2000). spr-2, a suppressor of the egg-laying defect caused by loss of sel-12 presenilin in Caenorhabditis elegans, is a member of the SET protein subfamily. Proc. Natl. Acad. Sci. U.S.A. 97, 14524-14529. doi: 10.1073/pnas.011446498
206. Wen, C., Metzstein, M. M., and Greenwald, I. (1997). SUP-17, a Caenorhabditis elegans ADAM protein related to Drosophila KUZBANIAN, and its role in LIN-12/NOTCH signalling. Development 124, 4759-4767. doi: 10.1101/gad.1039703.
207. Wenk, G. L., and Olton, D. S. (1987). "Basal forebrain cholinergic neurons and Alzheimer's disease," in Animal Models of Dementia: A Synaptic Neurochemical Perspective (Neurology and Neurobiology), ed. J. T. Coyle (New York: John Wiley & Sons), 81-101. doi: 10.1016/j.expneurol.2005.06.020
208. Wenk, G. L., and Olton, D. S. (1989). Cognitive enhancers: potetial strategies and experimental results. Prog. Neuropsychopharmacol. Biol. Psychiatry 13, S117-S139. doi: 10.1016/0278-5846(89)90115-2
209. Wentzell, J., and Kretzschmar, D. (2010). Alzheimer's disease and tauopathy studies in flies and worms. Neurobiol. Dis. 40, 21-28. doi: 10.1016/j.nbd.2010.03.007
210. Wentzell, J. S., Bolkan, B. J., Carmine-Simmen, K., Swanson, T. L., Musashe, D. T., and Kretzschmar, D. (2012). Amyloid precursor proteins are protective in Drosophila models of progressive neurodegeneration. Neurobiol. Dis. 46, 78-87. doi: 10.1016/j.nbd.2011.12.047
211. Westerman, M. A., Cooper-Blacketer, D., Mariash, A., Kotilinek, L., Kawarabayashi, T., Younkin, L. H., et al. (2002). The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease. J. Neurosci. 22, 1858-1867.
212. Willem, M., Garratt, A. N., Novak, B., Citron, M., Kaufmann, S., Rittger, A., et al. (2006). Control of peripheral nerve myelination by the beta-secretase BACE1. Science 314, 664-666. doi: 10.1126/science.1132341
213. Winkler, D. T., Biedermann, L., Tolnay, M., Allegrini, P. R., Staufenbiel, M., Wiessner, C., et al. (2002). Thrombolysis induces cerebral hemorrhage in a mouse model of cerebral amyloid angiopathy. Ann. Neurol. 51, 790-793. doi: 10.1002/ana.10210
214. Wirak, D. O., Bayney, R., Ramabhadran, T. V., Fracasso, R. P., Hart, J. T., Hauer, P. E., et al. (1991). Deposits of amyloid beta protein in the central nervous system of transgenic mice. Science 253, 323-325. doi: 10.1126/science.1857970
215. Yagi, T., Ito, D., Okada, Y., Akamatsu, W., Nihei, Y., Yoshizaki, T., et al. (2011). Modeling familial Alzheimer's disease with induced pluripotent stem cells. Hum. Mol. Genet. 20, 4530-4539. doi: 10.1093/hmg/ddr394
216. Yamaguchi, F., Richards, S. J., Beyreuther, K., Salbaum, M., Carlson, G. A., and Dunnett, S. B. (1991). Transgenic mice for the amyloid precursor protein 695 isoform have impaired spatial memory. Neuroreport 2, 781-784. doi: 10.1097/00001756-199112000-00013
217. Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., et al. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917-1920. doi: 10.1126/science.1151526
218. Zhan, M., Yamaza, H., Sun, Y., Sinclair, J., Li, H., and Zou, S. (2007). Temporal and spatial transcriptional profiles of aging in Drosophila melanogaster. Genome Res. 17, 1236-1243. doi: 10.1101/gr.6216607
219. Zheng, H., Jiang, M., Trumbauer, M. E., Hopkins, R., Sirinathsinghji, D. J., Stevens, K. A., et al. (1996). Mice deficient for the amyloid precursor protein gene. Ann. N. Y. Acad. Sci. 777, 421-426. doi: 10.1111/j.1749-6632.1996.tb34456.x
220. Zon, L. I., and Peterson, R. T. (2005). In vivo drug discovery in the zebrafish. Nat. Rev. Drug Discov. 4, 35-44. doi: 10.1038/nrd1606
221. Zou, S., Meadows, S., Sharp, L., Jan, L. Y., and Jan, Y. N. (2000). Genome-wide study of aging and oxidative stress response in Drosophila melanogaster. Proc. Natl. Acad. Sci. U.S.A. 97, 13726-13731. doi: 10.1073/pnas.260496697